Business Wire

Sintavia Inaugurates 55,000 Square Foot Advanced Manufacturing Facility

Share

Sintavia, LLC, the leading Tier One metal additive manufacturer for the Aerospace & Defense industry, has officially opened the doors to its new 55,000 square foot advanced manufacturing facility, located in Hollywood, Florida. The new plant, which also serves as the company’s headquarters, celebrated its grand opening on May 9th at an event with over 150 customers, industry partners, and government officials.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190513005786/en/

Sintavia's grand opening was attended by over 150 customers and industry partners on May 9th, 2019.  ...

Sintavia's grand opening was attended by over 150 customers and industry partners on May 9th, 2019. From left to right, Mayor Josh Levy, City of Hollywood; Mr. Masaki Nakajima, CEO and President of Sumitomo Corporation of Americas; Brian Neff, Sintavia's Founder, CEO, and Co-Owner; Jana Neff, Sintavia's Co-Owner; Mr. Toyoyuki Sato, Corporate Officer of Taiyo Nippon Sanso Corporation; and Dr. Wazir Ishmael, City Manager of Hollywood, Florida. (Photo: Business Wire)

“This new facility is the first of its kind in North America to offer large-scale AM production coupled with a robust aerospace quality management system,” said Brian Neff, Sintavia’s Chairman and Chief Executive Officer. “As we grow, it will serve as a template for future vertically-aligned advanced manufacturing facilities around the U.S. and the world.”

The grand opening was attended by over 150 customers and industry partners including Sumitomo Corporation, a growth equity investment partner of Sintavia and one of the largest international trading companies in the world. “Sintavia has again proven itself as a leader in the industrialization of AM production,” said Mr. Masaki Nakajima, CEO and President of Sumitomo Corporation of Americas. “We are excited to work with the entire Sintavia team in their new facility as they continue to grow.”

Sintavia’s new facility houses over $25 million of advanced manufacturing equipment including medium and large scale metal printers, EDMs, post-processing machines, wet-booths, and multiple furnaces. Some of the industrial engineering improvements of the building include separate manufacturing rooms segregated by alloy, a large-scale powder management system, an uninterruptable power supply, an inert gas farm, and a final production acceptance quality control room.

The new facility is capable of producing tens of thousands of parts representing in excess of $100mm of AM revenue annually. The expansion is anticipated to bring more than 130 new jobs for skilled employees and support staff to South Florida.

About Sintavia

Sintavia is the global leader for independent metal AM for the Aerospace & Defense industry. With high-speed printers co-located alongside precision post processing equipment, a full complement of mechanical testing equipment, and a full metallurgical and powder laboratory, Sintavia is able to optimize parameters, serially manufacture, and audit quality parts. Sintavia is committed to the highest quality standards and holds Nadcap, AS9100, ISO17025, and ANAB accreditation, and is OASIS and ITAR compliant.

Contact information

Carolyn Allan, +1 954.474.7800
Director of Marketing & Strategic Sales

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ZOOM International to Begin Doing Business As Elevēo2.6.2020 16:00:00 CESTPress release

ZOOM International a worldwide leader in omni-channel compliance recording, workforce optimization (WFO), and revenue protection software for contact centers will begin doing business solely as elevēo beginning June 2nd, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005093/en/ For over 20 years, ZOOM International has been a leading workforce optimization software provider in the contact center industry. Very early on, we were approached to solve a compliance problem with call recording. We built a creative software solution in record time, and began a journey crossing continents, employing hundreds of colleagues, and eventually improving operations, compliance, and customer experience for thousands of customers in 94 countries via more than 550 channel partners in the communications industry. Over time we have earned an 88 NPS score from ZOOM International customers & partners for our world-class support and in

Dr Evidence (DRE), an AI-Enabled SaaS Healthcare Insights Company, Taps Industry Experts Joseph A. Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its Newly Formed Medical Strategy Advisory Board2.6.2020 16:00:00 CESTPress release

DRE is pleased to welcome Joe Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its newly formed Medical Strategy Advisory Board (MSAB). These enhancements to the Company reflect the expanded need for keen guidance in this unprecedented time of convergence between expert AI-enabled technology in healthcare and the exponential growth of clinical information. DRE is dedicated to applying sophisticated data science with advanced AI to generate quicker, deeper, more nuanced regulatory-grade scientific and clinical insights for the betterment of patient outcomes. Boystak is an experienced healthcare venture capitalist and senior healthcare investment banker having been Founding Managing Partner at Health2047 Capital Partners and Founding Managing Director, Global Life Sciences at Jefferies. He is CEO of Brightwaters Capital and is a serial co-founder/investor in biomedical, med tech, health information technology, and artificial intelligence companies with spinouts fro

Andersen Global Expands Presence in Qatar2.6.2020 15:30:00 CESTPress release

Andersen Global announced its collaboration with Doha-based tax firm MS Partner, adding depth to the organization’s presence in Qatar and expanding its global platform. MS Partner was founded in 2018 and includes two Partners and more than 10 professionals that specialize in providing tax services to a variety of international clients including individuals and companies – both private and public. MS Partner’s Chairman His Excellency Shaikh Sultan Bin Jassim Bin Mohammed Al Thani is a prominent business leader in the State of Qatar. “We value our clients and people, and maintain the highest of professional standards,” said Office Managing Director Manikandan Rajan. “We’ve watched Andersen Global grow regionally as well as globally, and the organization has set the standard for providing clients with best-in-class service in an independent and seamless manner. We look forward to working closely with our fellow collaborating firm in Doha, Al-Khalifa Law, as well as all the collaborating f

Pegasus Development AG: Pegasus Present Its New Brand Pegastril - Nuevo2.6.2020 15:06:00 CESTPress release

The coronavirus pandemic harbours the potential for enormous growth in specific industries. To that end, however, it's important to identify which markets will be dominant in the future. One of the key growth sectors is the production and distribution of disinfectants and associated technologies. Regardless of whether a cure for, or vaccine against, COVID-19 is developed, protection against viruses and bacteria has become incredibly important across the globe and will continue to be a concern going forward. This was one of the reasons why Pegasus Development AG decided to partner with the British disinfectant manufacturer Nuevo. One of the decisive factors choosing Nuevo was its highly competitive product, which is free from alcohol, animal products, perfume, essential oils or dyes. Furthermore, the product has already been tested according to the highest stipulations of the European standard EN 1276, is manufactured according to the latest regulations of the European Biocides Directiv

PVH Corp. Announces Leadership Update at Tommy Hilfiger and PVH Europe2.6.2020 15:00:00 CESTPress release

PVH Corp. (NYSE:PVH), owner of a portfolio of iconic brands including TOMMY HILFIGER and CALVIN KLEIN, announced today that Daniel Grieder is stepping down from his role of Chief Executive Officer, Tommy Hilfiger Global & PVH Europe after 23 years in various management roles within the organization, and will be leaving the company to pursue other interests. Martijn Hagman will succeed Grieder and become the new Chief Executive Officer, Tommy Hilfiger Global & PVH Europe, effective June 2, 2020. Hagman is currently Chief Operating Officer, Tommy Hilfiger Global & PVH Europe and Chief Financial Officer, Tommy Hilfiger Global, overseeing operations, finance, digital business transformation, technology, business development and the Tommy Hilfiger global sustainability program. He is a 12-year veteran of the Tommy Hilfiger leadership team and has been instrumental in Tommy Hilfiger’s impressive global expansion and the strategy that has led to PVH Europe’s consistent year-over-year growth.

Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing2.6.2020 15:00:00 CESTPress release

Re-Vana Therapeutics Ltd, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, today announced that it has closed $3.25 million in pre-series A financing. The pre-series A round was oversubscribed by more than $1 million and closed in two tranches. The first tranche of $2.08 million was led by ExSight Ventures, with participation from InFocus Capital Partners and existing U.K. investors, including TechStart Ventures, Clarendon Fund Managers and Qubis Ltd. Visionary Ventures led the second closing round of $1.17 million, with additional investment from existing investors. With the second closing, Re-Vana became the first company in which all three specialized U.S. ophthalmic funds have invested in the same company. The proceeds will advance proof-of-concept development for Re-Vana’s proprietary photocrosslinked EyeLief™ and OcuLief™ biodegradable technologies for the delivery of biol